** Shares of India's MedPlus Health Services MEDP.NS jump as much as 12.2% to 1,022.20 rupees; last up 7.4%
** Pharmacy chain's Q4 net profit rose 24.6% y/y to 639.8 million rupees ($6.65 million)
** Revenue from ops rose 23.5% y/y, driven by store expansion and strong same-store growth
** Co adds 218 net stores in the quarter, compared with 100 a year earlier
** Consol operating EBITDA margin increased to 5.8% from 5.3% a year earlier
** Trading vols at 9.7x the 30-day average
** MEDP rated "strong buy" on average by seven analysts, median PT: 1,110 rupees - LSEG data
** YTD, stock up ~22.2%
($1 = 96.2200 Indian rupees)
(Reporting by Bipasha Dey in Bengaluru)
((Bipasha.Dey@thomsonreuters.com;))